Related Experiment Video
Updated: May 20, 2026

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Leptomeningeal metastasis from systemic cancer
1University of California, San Francisco, 400 Parnassus Avenue, A-808, Box 0372, San Francisco, CA 94143, USA. clarkej@neurosurg.ucsf.edu
Purpose Of Review:
Leptomeningeal metastasis (LM) is an uncommon, usually late, complication of cancer. This article discusses the clinical presentation, diagnosis, prognosis, and treatment of LM.
Recent Findings:
Neither gadolinium-enhanced MRI nor CSF cytology is adequately sensitive to diagnose all cases of LM.
Summary:
Patients with LM classically present with multifocal neurologic symptoms and signs, and the diagnosis is made via MRI, CSF cytologic analysis, or both. Treatment is palliative in nature and can involve focal radiation to symptomatic sites, systemic chemotherapy with agent(s) that cross the blood-brain barrier, or intrathecal delivery of chemotherapy. Patients may present with or later develop signs of hydrocephalus; ventriculoperitoneal shunting can provide symptomatic relief in certain patients. Overall prognosis is poor, with a median survival typically in the range of 2 to 3 months.
More Related Videos
07:17A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Published on: January 29, 2021
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Viral Meningitis
Brain Abscess l: Introduction
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: